Published in Neurology on August 10, 2005
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol (2010) 1.70
Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? J Neurol (2008) 1.59
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol (2008) 1.46
Multiple sclerosis and pregnancy: therapeutic considerations. J Neurol (2012) 1.32
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology (2012) 1.17
Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord (2013) 1.01
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA J (2012) 0.87
Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol (2009) 0.85
The interferon beta therapies for treatment of relapsing-remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination. Ther Adv Neurol Disord (2011) 0.82
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue. BMJ Case Rep (2014) 0.78
Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study. BMJ Open (2016) 0.76
Pregnancy and multiple sclerosis. Obstet Med (2012) 0.75
Interferon beta babies. Neurology (2005) 0.75
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks. Mult Scler Int (2016) 0.75
Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach. J Neurol (2006) 0.75
Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy. Hepatol Res (2013) 0.75
[Recent advances in the pathogenesis and immunotherapy of multiple sclerosis]. Nervenarzt (2007) 0.75
[Subcutaneous interferon-beta-1a in the treatment of multiple sclerosis]. Wien Med Wochenschr (2008) 0.75
Impairment of human neural crest cell migration by prolonged exposure to interferon-beta. Arch Toxicol (2017) 0.75
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med (1984) 6.74
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 6.58
How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics (1967) 5.82
Sp1 elements protect a CpG island from de novo methylation. Nature (1994) 5.60
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Oceanic forcing of Sahel rainfall on interannual to interdecadal time scales. Science (2003) 5.06
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial. Neurology (2002) 3.73
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res (1997) 3.55
Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med (1997) 3.32
Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol (1997) 3.03
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA (1999) 2.74
Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet (1990) 2.72
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun (1995) 2.48
Axillary breast tissue: clinical presentation and surgical treatment. Ann Plast Surg (1995) 2.46
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet (2004) 2.40
Quantification of flow through an interatrial communication. Application to the partial Fontan procedure. J Thorac Cardiovasc Surg (1992) 2.39
Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem (2000) 2.37
Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med (1994) 2.35
Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol (1994) 2.33
The PKD1 gene produces a developmentally regulated protein in mesenchyme and vasculature. Nat Med (1995) 2.30
Gallbladder contractility in patients with spinal cord injuries: a sonographic investigation. AJR Am J Roentgenol (1990) 2.24
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med (1985) 2.22
Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J Biol Chem (1994) 2.17
Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04
Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol (1999) 1.92
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J Exp Med (1993) 1.91
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol (1982) 1.91
The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun (1992) 1.86
Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol (1983) 1.80
Brachial plexus palsy: an in utero injury? Am J Obstet Gynecol (1999) 1.76
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun (2001) 1.75
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol (1996) 1.67
The neurohumoral axis in congestive heart failure. Ann Intern Med (1984) 1.66
Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol (1995) 1.66
Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric? Clin Pharmacol Ther (2009) 1.66
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol (1995) 1.65
Maximal exercise tolerance as a therapeutic end point in heart failure--are we relying on the right measure? Am J Cardiol (1994) 1.64
Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol (1985) (1993) 1.64
Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. J Am Coll Cardiol (1992) 1.64
Spontaneous vaginal delivery: a risk factor for Erb's palsy? Am J Obstet Gynecol (1998) 1.63
Obstetric maneuvers for shoulder dystocia and associated fetal morbidity. Am J Obstet Gynecol (1998) 1.63
The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol (2006) 1.59
ACE inhibition in cardiovascular disease. N Engl J Med (2000) 1.58
Hypoxaemia in children with severe pneumonia in Papua New Guinea. Int J Tuberc Lung Dis (2001) 1.57
Cardiac troponins and chronic kidney disease. Kidney Int (2006) 1.57
Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J (1982) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum Mol Genet (1997) 1.56
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Coronary sinus ostial occlusion during retrograde delivery of cardioplegic solution significantly improves cardioplegic distribution and efficacy. J Thorac Cardiovasc Surg (1995) 1.55
Intestinal perforation associated with cytomegalovirus infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol (1984) 1.54
Localization of specific mRNAs in Xenopus embryos by whole-mount in situ hybridization. Development (1990) 1.52
HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups. Neurology (1993) 1.52
Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail (1995) 1.52
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr (1988) 1.49
Characteristics of pronuclear migration in Beroe ovata. Cell Motil Cytoskeleton (1994) 1.48
Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-perform screening strategy. J Clin Microbiol (1998) 1.48
Stillbirth evaluation: what tests are needed? Am J Obstet Gynecol (1998) 1.48
Neurohumoral control mechanisms in congestive heart failure. Am Heart J (1981) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Analysis of prepro-alpha-lytic protease expression in Escherichia coli reveals that the pro region is required for activity. J Bacteriol (1989) 1.45
Intrapartum rupture of the unscarred uterus. Obstet Gynecol (1997) 1.44
Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia. J Thorac Cardiovasc Surg (1993) 1.42
A technique for laparoscopic completion of vaginal hysterectomy. Obstet Gynecol (1996) 1.41
Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed high-dose oral dexamethasone. Am J Obstet Gynecol (1997) 1.41
Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci (1999) 1.40
HTLV-1 associated myelopathy in Canada. Can J Neurol Sci (1989) 1.40
Postnatal management of antenatal hydronephrosis. BJU Int (2002) 1.39
The heterotopic right heart assist transplantation. J Heart Transplant (1988) 1.39
Polymorphic reticulosis: a malignant lymphoma of B-cell lineage. Laryngoscope (1989) 1.39
Model-based 3-D segmentation of multiple sclerosis lesions in magnetic resonance brain images. IEEE Trans Med Imaging (1995) 1.39
Serendipity in diagnostic imaging: magnetic resonance imaging of the breast. J Natl Cancer Inst (1998) 1.38
Syk tyrosine kinase is required for immunoreceptor tyrosine activation motif-dependent actin assembly. J Biol Chem (1996) 1.36
Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol (1999) 1.35
Systemic alpha-interferon therapy of multiple sclerosis. Neurology (1984) 1.35
IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet (1998) 1.35
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis. Mult Scler (2005) 1.31
A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol (1995) 1.30
Effect of in vitro DNA methylation on beta-globin gene expression. Proc Natl Acad Sci U S A (1988) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc Natl Acad Sci U S A (2000) 1.26
Clustered syk tyrosine kinase domains trigger phagocytosis. Proc Natl Acad Sci U S A (1996) 1.25
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol (1992) 1.24
FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem Biophys Res Commun (2001) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23